Lamisil At

Terbinafine Hydrochloride, the active ingredient in Lamisil At, is an allylamine antifungal presented as a topical formulation for skin use. It treats dermatophyte infections of the skin such as athlete's foot, ringworm and jock itch by eliminating the causative fungus. GNH USA supplies Lamisil At as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil At is an allylamine antifungal indicated for dermatophyte skin infections. - Athlete's foot (tinea pedis): reduces fungal growth and clears infection of the feet. - Ringworm (tinea corporis): alleviates lesions and prevents spread across the body. - Jock itch (tinea cruris): improves itching and resolves rash in the groin area.

Lamisil At may cause local skin reactions and, in rare cases, systemic effects.

Common Side Effects: - Burning sensation at the application site - Itching or pruritus - Redness or erythema - Dryness or peeling of the skin - Scaling or flaking - Mild irritation

Serious or Rare Side Effects: - Severe allergic reaction (angioedema, swelling) - Contact dermatitis with extensive rash - Blistering or bullous skin lesions - Systemic absorption leading to liver enzyme elevation - Unexplained fever or malaise - Persistent swelling or ulceration at the site

Before using Lamisil At, consider the following safety measures. - Apply to intact skin only: avoid broken skin, mucous membranes, or open wounds. - Limit use to affected areas: do not cover large body surface areas without medical advice. - Avoid if known hypersensitivity to terbinafine or formulation excipients. - Consult a healthcare professional before use in children, elderly, or patients with liver disease. - Discontinue if severe irritation, rash, or swelling develops. - Store at room temperature: keep in the original container, protect from moisture and heat.

Terbinafine may interact with other medications or substances.

Major Interactions (Avoid): - Systemic antifungals (e.g., itraconazole): may increase systemic exposure to terbinafine. - Strong CYP450 inhibitors (e.g., ketoconazole): can raise terbinafine levels and risk toxicity. - Topical corticosteroids: may reduce the antifungal efficacy of Lamisil At.

Moderate Interactions (Monitor Closely): - Alcohol consumption: may increase skin irritation. - Other topical agents (e.g., salicylic acid, urea): could affect absorption or cause irritation. - Hormonal contraceptives: limited data, monitor for any changes in efficacy.